What is Ezetimibe?

Ezetimibe is a new-generation drug used to reduce total cholesterol and, in particular, LDL cholesterol, contributing to the prevention of cardiovascular disease. Unlike statins, which act mainly on the liver, ezetimibe works in a different way: it blocks the absorption of cholesterol in the intestine, both that introduced through food and that present in bile, preventing it from entering the bloodstream.

Thanks to this complementary mechanism, ezetimibe effectively combines with statins, enhancing their lipid-lowering action without significantly increasing the burden on the liver.

The drug is particularly useful in athletes who use PEDs, especially anabolic steroids (AAS), which are known to alter the lipid profile by increasing LDL and reducing HDL, resulting in an increased cardiovascular risk.

Main effects of Ezetimibe

📉 Significant reduction in LDL cholesterol
🔽 Moderate decrease in total cholesterol and triglycerides
🛡️ Better maintenance of HDL levels when combined with statins (e.g., pitavastatin)
🍃 Less impact on the liver compared to statin therapy alone
🫀 Additional cardiovascular support for PED users

How to take Ezetimibe

Dosage and method of use

When using AAS, ezetimibe is taken at the same dosage for the entire duration of the cycle, continuing for an additional 4–6 weeks after the end of the cycle to stabilize the lipid profile and protect the cardiovascular system.

The standard dose of 10 mg per day is generally sufficient and does not require increases. Any continuation or modification of therapy should be based on periodic monitoring of lipids (LDL, HDL, total cholesterol, triglycerides) and liver enzymes (ALT, AST).

Precautions

• Avoid combination with cyclosporine (possible increase in plasma concentrations).

• Monitor liver function during combination therapy with statins.

• Use with caution in patients with pre-existing liver disease.

Possible side effects

• Mild gastrointestinal disorders (diarrhea, abdominal pain)

• Headache

• Fatigue

• When used in combination with statins, there may be an increased risk of muscle pain compared to monotherapy.

Storage

Store in a dry place at a temperature below 25°C, away from sunlight.
Keep out of the reach of children and do not use after the expiry date.

Mechanism of action of Ezetimibe

Ezetimibe acts in the small intestine, the main site of absorption of dietary and bile cholesterol. The drug selectively inhibits the NPC1L1 (Niemann-Pick C1-like 1) transport protein, which is responsible for the passage of cholesterol from intestinal cells into the blood. By blocking this transporter, cholesterol is eliminated through the intestine instead of entering the bloodstream.

The reduction in absorbed cholesterol causes the liver to increase the expression of LDL receptors, promoting the removal of "bad" cholesterol from the blood and reducing its deposition on the vascular walls.

In combination with statins, which reduce hepatic cholesterol synthesis, the effect is synergistic and leads to a marked decrease in atherosclerotic risk. This combination is particularly recommended for athletes who take AAS, as these substances significantly alter lipid balance, increasing cardiovascular stress.

Frequently Asked Questions

Can ezetimibe be taken with statins such as pitavastatin, atorvastatin, or rosuvastatin?
Yes, this combination is common and allows for a more effective reduction in LDL cholesterol.

Does it negatively affect training or muscle recovery?
No, ezetimibe does not compromise muscle function or recovery times.

Does it reduce the absorption of vitamins or nutrients?
At high doses, it may slightly reduce the absorption of fat-soluble vitamins (A, D, E, and K), but this is rare with the standard dosage.